As of 2025-05-31, the Fair Value of Vertex Pharmaceuticals Inc (VRTX) is -40.62 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 442.05 USD, the upside of Vertex Pharmaceuticals Inc is -109.19%.
With the market price of 442.05 USD and our fair value calculation, Vertex Pharmaceuticals Inc (VRTX) is not a good investment. Investing in Vertex stocks now will result in a potential loss of 109.19%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 2,711.60 | 2,342.10 | 3,322.00 | 3,619.60 | -535.60 | 2,291.94 |
| YoY growth | 130.42% | -13.63% | 41.84% | 8.96% | -114.80% | 10.56% |
| Market Cap (mil) | 113,642.21 |
| P/E | |
| Forward P/E | 410.92x |
| EPS | -3.85 |
| Avg earnings growth rate | 10.56% |
| TTM earnings | -988.90 |